Welcome to Actinic Keratosis Update! This is a self-paced e-Learning course about the latest in Actinic Keratosis. We introduce you to the course Clinical Considerations around Skin Cancer: Melanoma and Non-Melanoma Skin Cancer, prepared by international field experts Prof. Giuseppe Argenziano, Professor of Dermatology and Chairman of the Dermatology Unit of the University of Campania Luigi Vanvitelli, Naples (Italy), and Dr. Carla Ferrándiz, Assistant Professor of Dermatology at Universitat Autònoma de Barcelona and Consultant Dermatologist at Dermatology Department, Hospital Universitari Vall d’Hebron, Barcelona (Spain).

The entire course is provided by Lexic, a medical education and communication agency with extensive experience at European level.

We are very pleased to share with you interesting and novel information through our innovative, interactive, online medical education programs. The resources learners will find in this first course are:

  • Two Video Lessons of approximately 20 minutes
  • A short Satisfaction Survey
  • An Accreditation Test

The total duration of the course is estimated at 60-75 minutes, depending on learners’ pace. Please, remember you need to complete the entire training in order to access the test to pass the course. The test consists of 10 questions and you can only take it twice. In order to successfully pass it, you need 80% of correct answers, which means answering 8 questions correctly. Remember that before taking the test you can review the video presentation as many times as you need.


Actinic Keratosis Update is aimed at providing you with the latest knowledge in the management of actinic keratosis lesions to help you improve your daily clinical practice and to take care of your patients the best way possible. We really hope you find this course useful and enjoyable.


Actinic keratosis is important in order to prevent skin cancer because patients with multiple actinic keratosis are at risk of skin cancer: 65% of squamous cell carcinomas arise on a preexisting actinic keratosis. For professionals, the main problem is cancer’s morbidity and mortality.